.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Medtronic
QuintilesIMS
Cerilliant
UBS
Federal Trade Commission
US Army
Julphar
Cantor Fitzgerald
Express Scripts

Generated: July 20, 2017

DrugPatentWatch Database Preview

Dronabinol - Generic Drug Details

« Back to Dashboard

What are the generic sources for dronabinol and what is the scope of dronabinol freedom to operate?

Dronabinol
is the generic ingredient in three branded drugs marketed by Insys Therap, Akorn Inc, Insys Dev Co Inc, Abbvie, and Svc Pharma, and is included in five NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Dronabinol has four patent family members in four countries.

There are eleven drug master file entries for dronabinol. Seven suppliers are listed for this compound.

Summary for Generic Name: dronabinol

Tradenames:3
Patents:3
Applicants:5
NDAs:5
Drug Master File Entries: see list11
Suppliers / Packagers: see list7
Bulk Api Vendors: see list15
Clinical Trials: see list54
Patent Applications: see list5,665
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dronabinol at DailyMed

Pharmacology for Ingredient: dronabinol

Ingredient-typeCannabinoids
Drug ClassCannabinoid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-001Jun 20, 2014ABRXNoNo► Subscribe► Subscribe
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-003Jun 20, 2014ABRXNoNo► Subscribe► Subscribe
Insys Dev Co Inc
SYNDROS
dronabinol
SOLUTION;ORAL205525-001Mar 23, 2017RXYesYes8,222,292► SubscribeYY ► Subscribe
Insys Therap
DRONABINOL
dronabinol
CAPSULE;ORAL078501-001Aug 19, 2011DISCNNoNo► Subscribe► Subscribe
Akorn Inc
DRONABINOL
dronabinol
CAPSULE;ORAL079217-002Jun 20, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dronabinol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-001May 31, 19856,703,418► Subscribe
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-003May 31, 19856,703,418► Subscribe
Abbvie
MARINOL
dronabinol
CAPSULE;ORAL018651-002May 31, 19856,703,418► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: dronabinol

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2009020666► Subscribe
Canada2698752► Subscribe
Japan2010535774► Subscribe
European Patent Office2184983► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Accenture
Novartis
AstraZeneca
QuintilesIMS
Chinese Patent Office
Cipla
Queensland Health
Argus Health
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot